SLEAP SMART (Sleep Apnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke): A Randomized Controlled Trial.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 12 10 2021
medline: 11 3 2022
entrez: 11 10 2021
Statut: ppublish

Résumé

Poststroke/transient ischemic attack obstructive sleep apnea (OSA) is prevalent, linked with numerous unfavorable health consequences, but remains underdiagnosed. Reasons include patient inconvenience and costs associated with use of in-laboratory polysomnography (iPSG), the current standard tool. Fortunately, home sleep apnea testing (HSAT) can accurately diagnose OSA and is potentially more convenient and cost-effective compared with iPSG. Our objective was to assess whether screening for OSA in patients with stroke/transient ischemic attack using HSAT, compared with standard of care using iPSG, increased diagnosis and treatment of OSA, improved clinical outcomes and patient experiences with sleep testing, and was a cost-effective approach. We consecutively recruited 250 patients who had sustained a stroke/transient ischemic attack within the past 6 months. Patients were randomized (1:1) to use of (1) HSAT versus (2) iPSG. Patients completed assessments and questionnaires at baseline and 6-month follow-up appointments. Patients diagnosed with OSA were offered continuous positive airway pressure. The primary outcome was compared between study arms via an intention-to-treat analysis. At 6 months, 94 patients completed HSAT and 71 patients completed iPSG. A significantly greater proportion of patients in the HSAT arm were diagnosed with OSA (48.8% versus 35.2%, In patients with stroke/transient ischemic attack, use of HSAT compared with iPSG increases the rate of OSA diagnosis and treatment, reduces daytime sleepiness, improves functional outcomes and experiences with sleep testing, and could be an economically attractive approach. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02454023.

Sections du résumé

BACKGROUND AND PURPOSE
Poststroke/transient ischemic attack obstructive sleep apnea (OSA) is prevalent, linked with numerous unfavorable health consequences, but remains underdiagnosed. Reasons include patient inconvenience and costs associated with use of in-laboratory polysomnography (iPSG), the current standard tool. Fortunately, home sleep apnea testing (HSAT) can accurately diagnose OSA and is potentially more convenient and cost-effective compared with iPSG. Our objective was to assess whether screening for OSA in patients with stroke/transient ischemic attack using HSAT, compared with standard of care using iPSG, increased diagnosis and treatment of OSA, improved clinical outcomes and patient experiences with sleep testing, and was a cost-effective approach.
METHODS
We consecutively recruited 250 patients who had sustained a stroke/transient ischemic attack within the past 6 months. Patients were randomized (1:1) to use of (1) HSAT versus (2) iPSG. Patients completed assessments and questionnaires at baseline and 6-month follow-up appointments. Patients diagnosed with OSA were offered continuous positive airway pressure. The primary outcome was compared between study arms via an intention-to-treat analysis.
RESULTS
At 6 months, 94 patients completed HSAT and 71 patients completed iPSG. A significantly greater proportion of patients in the HSAT arm were diagnosed with OSA (48.8% versus 35.2%,
CONCLUSIONS
In patients with stroke/transient ischemic attack, use of HSAT compared with iPSG increases the rate of OSA diagnosis and treatment, reduces daytime sleepiness, improves functional outcomes and experiences with sleep testing, and could be an economically attractive approach. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02454023.

Identifiants

pubmed: 34628939
doi: 10.1161/STROKEAHA.120.033753
doi:

Banques de données

ClinicalTrials.gov
['NCT02454023']

Types de publication

Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

710-718

Commentaires et corrections

Type : CommentIn

Auteurs

Mark I Boulos (MI)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Maneesha Kamra (M)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

David R Colelli (DR)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Nardin Kirolos (N)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

David J Gladstone (DJ)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Karl Boyle (K)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Arun Sundaram (A)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Julia J Hopyan (JJ)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Richard H Swartz (RH)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Muhammad Mamdani (M)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Desmond Loong (D)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Wanrudee Isaranuwatchai (W)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Brian J Murray (BJ)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Kevin E Thorpe (KE)

Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., M.K., D.R.C., N.K., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.).
Department of Medicine, Division of Neurology (M.I.B., D.J.G., K.B., A.S., J.J.H., R.H.S., B.J.M.), University of Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation (D.L., W.I.), University of Toronto, Ontario, Canada.
Applied Health Research Centre & Dalla Lana School of Public Health (K.E.T.), University of Toronto, Ontario, Canada.
Sleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (M.I.B., B.J.M.).
Stroke Medicine, Beaumont Hospital, Dublin, Ireland (K.B.).
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada (M.M., D.L., W.I).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH